Dimitra Georganopoulou, PhD
Director of Commercialization
Phone: (847) 467-3095
Dimitra is an experienced professional in the MedTech Sector, with expertise in medical devices, diagnostics, Health IT and personalized medicine projects within start-up environments. She is currently involved in managing innovation, product development, intellectual property and licensing for multiple projects affiliated with Northwestern’s Innovation and New Ventures Office. Dimitra acts as a liaison of the office and actively pursues Business Development opportunities for inventors, which range from start-up ventures to strategic partnerships.
Prior to joining Northwestern, Dimitra was the VP of R&D of Ohmx Corporation, a diagnostic company with novel POC (point-of-care) technology and prior to that she had worked for Nanosphere (now Luminex) and Inverness Medical (now Alere) for biosensor development.
Dimitra is the Chair Elect of the Chicago AACC (American Associate of Clinical Chemistry), and she sits on the board of Women in BIO, the AHA’s Heart Innovation Forum - Executive Leadership Team and is part of Springboard’s Executive Alum committee. She is also an active contributor to the local tech and life sciences community by participating in assessment and promoting entrepreneurship programs and ventures.
Dimitra earned a Ph.D. in Bioelectrochemistry from University College London (UCL), an M.Sc. in Biosensors from King’s College London, and a B.S. in from University of Thessaloniki, Greece. Her post-doctoral work at UNC and her research at Northwestern focused on nanoparticle based diagnostics. She is the author of numerous peer-reviewed publications and patents.